Surmodics gets IDE approval for drug-coated balloon; Adherium heralds data for its asthma-treating Smartinhaler;

> Surmodics ($SRDX) picked up the FDA's IDE approval for an early feasibility study of its SurVeil drug-coated balloon. Release

> Adherium presented new data on its Smartinhaler that showed increased adherence and a reduction in severe asthma attacks. Release

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.